Regulus Therapeutics to Present at the H.C. Wainwright 22nd Annual Virtual Global Investment Confere | RGLS Message Board Posts

Regulus Therapeutics Inc.

  RGLS website
  • Here We Go Again: Apparently, it's just one of those years. We here in the Greater New Orleans Area now find ourselves "in the cone" for the 7th time this year. And while we more or less dodged bullets the first 6 times, it looks like this time Zeta is going to hit close enough to do damage. We can only hope it stays a relatively minor Cat 1 & weakens upon approach. But preparations are once again in order for those of us living along the central Gulf Coast. Members with family or other interests in the affected area are welcome to post on the new Hurricane Zeta Self-Help board we just set up. Good luck & stay safe! 

RGLS   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  620 of 629  at  9/11/2020 8:51:39 AM  by

Steve_382


Regulus Therapeutics to Present at the H.C. Wainwright 22nd Annual Virtual Global Investment Conference

 Another presentation coming. They may not be successful, but at least it seems like they are trying again after a couple years of nothing.
 
 
Regulus Therapeutics to Present at the H.C. Wainwright 22nd Annual Virtual Global Investment Conference

LA JOLLA, Calif., Sept. 11, 2020 /PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs ("Regulus"), today announced that Jay Hagan, President and Chief Executive Officer of Regulus, will present at the H.C. Wainwright 22nd Annual Global Investment Conference on Tuesday, September 15, 2020 at 11:00 AM EDT.

A live webcast of the presentation will be available through the investor relations section of the Company's website at www.regulusrx.com.

About Regulus

Regulus Therapeutics Inc. (Nasdaq: RGLS) is a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs. Regulus has leveraged its oligonucleotide drug discovery and development expertise to develop a pipeline complemented by a rich intellectual property estate in the microRNA field. Regulus maintains its corporate headquarters in La Jolla, CA.

 


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 0     Views: 51
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
625 Re: Regulus Therapeutics to Present at the H.C. Wainwright 22nd Annual Virtual Global Investment Conference Steve_382 1 9/15/2020 11:27:58 AM






Financial Market Data provided by
.
Loading...